Indonesia · Delayed Price · Currency is IDR PT Suparma Tbk Statistics
Total Valuation
PT Suparma Tbk has a market cap or net worth of IDR 893.87 billion. The enterprise value is 1.41 trillion.
| Market Cap | 893.87B |
| Enterprise Value | 1.41T |
Important Dates
The next estimated earnings date is Tuesday, July 28, 2026.
| Earnings Date | Jul 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PT Suparma Tbk has 4.10 billion shares outstanding. The number of shares has increased by 1.33% in one year.
| Current Share Class | 4.10B |
| Shares Outstanding | 4.10B |
| Shares Change (YoY) | +1.33% |
| Shares Change (QoQ) | -1.42% |
| Owned by Insiders (%) | 81.58% |
| Owned by Institutions (%) | 0.02% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 8.38.
| PE Ratio | 8.38 |
| Forward PE | n/a |
| PS Ratio | 0.33 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.36 |
| P/FCF Ratio | 1.65 |
| P/OCF Ratio | 1.52 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.11, with an EV/FCF ratio of 2.59.
| EV / Earnings | 13.26 |
| EV / Sales | 0.51 |
| EV / EBITDA | 4.11 |
| EV / EBIT | 7.13 |
| EV / FCF | 2.59 |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.29.
| Current Ratio | 2.00 |
| Quick Ratio | 0.54 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 2.08 |
| Debt / FCF | 1.31 |
| Interest Coverage | 4.41 |
Financial Efficiency
Return on equity (ROE) is 4.36% and return on invested capital (ROIC) is 5.12%.
| Return on Equity (ROE) | 4.36% |
| Return on Assets (ROA) | 3.50% |
| Return on Invested Capital (ROIC) | 5.12% |
| Return on Capital Employed (ROCE) | 6.85% |
| Weighted Average Cost of Capital (WACC) | 6.74% |
| Revenue Per Employee | 3.31B |
| Profits Per Employee | 128.14M |
| Employee Count | 829 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 2.34 |
Taxes
In the past 12 months, PT Suparma Tbk has paid 30.51 billion in taxes.
| Income Tax | 30.51B |
| Effective Tax Rate | 22.31% |
Stock Price Statistics
The stock price has increased by +8.00% in the last 52 weeks. The beta is 0.72, so PT Suparma Tbk's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +8.00% |
| 50-Day Moving Average | 223.92 |
| 200-Day Moving Average | 233.61 |
| Relative Strength Index (RSI) | 50.21 |
| Average Volume (20 Days) | 356,230 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Suparma Tbk had revenue of IDR 2.74 trillion and earned 106.23 billion in profits. Earnings per share was 26.00.
| Revenue | 2.74T |
| Gross Profit | 434.43B |
| Operating Income | 197.61B |
| Pretax Income | 136.74B |
| Net Income | 106.23B |
| EBITDA | 343.00B |
| EBIT | 197.61B |
| Earnings Per Share (EPS) | 26.00 |
Balance Sheet
The company has 198.04 billion in cash and 712.49 billion in debt, with a net cash position of -514.45 billion or -125.47 per share.
| Cash & Cash Equivalents | 198.04B |
| Total Debt | 712.49B |
| Net Cash | -514.45B |
| Net Cash Per Share | -125.47 |
| Equity (Book Value) | 2.49T |
| Book Value Per Share | 607.14 |
| Working Capital | 779.29B |
Cash Flow
In the last 12 months, operating cash flow was 587.58 billion and capital expenditures -44.85 billion, giving a free cash flow of 542.72 billion.
| Operating Cash Flow | 587.58B |
| Capital Expenditures | -44.85B |
| Depreciation & Amortization | 145.39B |
| Net Borrowing | -657.37B |
| Free Cash Flow | 542.72B |
| FCF Per Share | 132.36 |
Margins
Gross margin is 15.85%, with operating and profit margins of 7.21% and 3.88%.
| Gross Margin | 15.85% |
| Operating Margin | 7.21% |
| Pretax Margin | 4.99% |
| Profit Margin | 3.88% |
| EBITDA Margin | 12.51% |
| EBIT Margin | 7.21% |
| FCF Margin | 19.80% |
Dividends & Yields
PT Suparma Tbk does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.33% |
| Shareholder Yield | -1.33% |
| Earnings Yield | 11.88% |
| FCF Yield | 60.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 10, 2025. It was a forward split with a ratio of 1.3.
| Last Split Date | Nov 10, 2025 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |